XOMA Royalty (XOMA) EBT Margin (2011 - 2026)

XOMA Royalty (XOMA) reported EBT Margin of 36.26% for Q1 2026, down 2292.0% on a YoY basis from 1.65% in Q1 2025, and down 45.73% sequentially from 66.81% in Q4 2025.

XOMA Royalty (XOMA) EBT Margin (2011 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 16 years of EBT Margin data on file, last reported at 36.26% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 2292.0% year-over-year to 36.26%; the trailing twelve-month figure through Mar 2026 stood at 13.99% (up 32193.0% YoY), and the FY2025 full-year result was 61.01%, up 35290.0% from the prior year.
  • EBT Margin eased to 36.26% in Q1 2026, from 66.81% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 66.81% in Q4 2025 to a low of 5593.78% in Q3 2023.
  • A 5-year average of 1390.03% and a median of 730.17% in 2024 frame the typical range for EBT Margin.
  • Across the five-year window, EBT Margin tumbled 1570959 bps in 2022 and surged 535419 bps in 2024, its largest moves.
  • Tracing XOMA's EBT Margin over 5 years: stood at 736.59% in 2022, then slumped by 112 bps to 1565.23% in 2023, then slipped by 22 bps to 1911.6% in 2024, then soared by 103 bps to 66.81% in 2025, then slumped by 46 bps to 36.26% in 2026.
  • Business Quant data shows XOMA's EBT Margin at 36.26% in Q1 2026, 66.81% in Q4 2025, and 221.13% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 XOMA Royalty 478.42 Mn 412.34 Mn - 36.26%

Historic Data

Download Data
DateValue
Mar 31, 2026 36.26%
Dec 31, 2025 66.81%
Jun 30, 2025 -221.13%
Mar 31, 2025 59.18%
Dec 31, 2024 -1,911.60%
Sep 30, 2024 -239.59%
Jun 30, 2024 -538.49%
Mar 31, 2024 -723.76%
Dec 31, 2023 -1,565.23%
Sep 30, 2023 -5,593.78%
Jun 30, 2023 -1,048.67%
Mar 31, 2023 -2,532.49%
Dec 31, 2022 -736.59%
Sep 30, 2022 -3,249.67%
Jun 30, 2022 -3,964.76%
Mar 31, 2022 -76.91%
Dec 31, 2021 14,973.00%
Sep 30, 2021 -806.55%
Jun 30, 2021 -248.28%
Mar 31, 2021 -1,966.13%